Apnimed prices IPO at $16 per share, raising $192 million
Source Summary
Apnimed has priced its initial public offering at $16 per share, raising $192 million through the transaction. This marks the company's entry into the public markets.
In depth
Apnimed has completed the pricing of its IPO at $16 per share, generating $192 million in capital through this public offering. The transaction represents the company's transition to public ownership and provides it with capital for operations and growth initiatives.
